Bharat Bio successfully completes Phase III trials of new oral...

Dununu.com Dununu

Sponsorizzato

Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol

RSS Feed National

Posted

98

Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving effective against both Ogawa and Inaba serotypes. The vaccine exhibited a significant rise in vibriocidal antibodies and maintained a strong safety profile across all age groups. With production capacity of 200 million doses, Hillchol can address the global cholera crisis and vaccine shortages.

Read Full Article

Effettua l'accesso per mettere mi piace, condividere e commentare!

Kerala DHSE Plus 2 results 2025 declared with 77.81% pass percentage: Girls outperform boys; Science stream records highest success

By 0 2

Janamat Party preparing to recall two ministers from Madesh Province govt

JANAKPURDHAM: The Janamat Party is preparing to recall two of its ministers currently serving in...

By 0 2

What is China's space mission Tianwen-2?

China's Tianwen-2 mission, set to launch in late May 2025, marks the nation's first endeavor to...

By 0 12

Heated exchange erupts between PAC Chair Pokharel and lawmaker Modi

KATHMANDU: A verbal dispute erupted between Rishikesh Pokharel, Chairperson of the Public...

By 0 24

One month since Pahalgam attack: How India has punished, isolated Pakistan since April 22

By 0 28